Evidence map›Paper›PMID 25959545›Full record

ArticleAnnals of human genetics2015

SVSI: fast and powerful set-valued system identification approach to identifying rare variants in sequencing studies for ordered categorical traits.

Wenjian Bi, Guolian Kang, Yanlong Zhao, Yuehua Cui, Song Yan, Yun Li, Cheng Cheng, Stanley B Pounds, Michael J Borowitz, Mary V Relling and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in Annals of human genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00137111 (Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00137111 phase3completednot on this map

Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia

TypeinterventionalSponsorSt. Jude Children's Research HospitalRan2000 to 2014Enrolled501ConditionsLymphoblastic Leukemia, AcuteArmsPrednisone, Dexamethasone, Vincristine, Daunorubicin, Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase, Methotrexate, Cyclophosphamide, Cytarabine, Etoposide, Mercaptopurine, Imatinib, chemotherapy, intrathecal chemotherapy
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Wenjian Bi *Key Laboratory of Systems and Control, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing 100190, P.R.C.
Guolian Kang *Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, U.S.A.
Yanlong ZhaoKey Laboratory of Systems and Control, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing 100190, P.R.C.
Yuehua CuiDepartment of Statistics and Probability, Michigan State University, East Lansing, Michigan 48824, U.S.A.
Song YanDepartment of Genetics, Department of Biostatistics, University of North Carolina, Chapel Hill, NC 27599, U.S.A.
Yun LiDepartment of Genetics, Department of Biostatistics, University of North Carolina, Chapel Hill, NC 27599, U.S.A.
Cheng ChengDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, U.S.A.
Stanley B PoundsDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, U.S.A.
Michael J BorowitzJohns Hopkins Medical Institute, Baltimore, MD 21231, U.S.A.
Mary V RellingDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, U.S.A.
Jun J YangDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, U.S.A.
Zhifa LiuDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, U.S.A.
Ching-Hon PuiDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, U.S.A.
Stephen P HungerUniversity of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado 80045, U.S.A.
Christine M HartfordDepartment of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, U.S.A.
Wing LeungDepartment of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, U.S.A.
Ji-Feng ZhangKey Laboratory of Systems and Control, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing 100190, P.R.C.

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
GENETIC ANALYSIS OF COMMON DISEASES: AN EVALUATIONR01GM031575 · NIGMS · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI ALMASY, LAURA A. · 1985 to 2016
$7.8M
Design and Analysis of Sequencing-based Studies for Complex Human TraitsR01HG006292 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, YUN · 2011 to 2015
$1.8M
NCI NIH HHS P30 CA021765NHGRI NIH HHS R01 HG006292NIGMS NIH HHS R01 GM031575
6 · The paper itself

Abstract

In genetic association studies of an ordered categorical phenotype, it is usual to either regroup multiple categories of the phenotype into two categories and then apply the logistic regression (LG), or apply ordered logistic (oLG), or ordered probit (oPRB) regression, which accounts for the ordinal nature of the phenotype. However, they may lose statistical power or may not control type I error due to their model assumption and/or instable parameter estimation algorithm when the genetic variant is rare or sample size is limited. To solve this problem, we propose a set-valued (SV) system model to identify genetic variants associated with an ordinal categorical phenotype. We couple this model with a SV system identification algorithm to identify all the key system parameters. Simulations and two real data analyses show that SV and LG accurately controlled the Type I error rate even at a significance level of 10(-6) but not oLG and oPRB in some cases. LG had significantly less power than the other three methods due to disregarding of the ordinal nature of the phenotype, and SV had similar or greater power than oLG and oPRB. We argue that SV should be employed in genetic association studies for ordered categorical phenotype.

Indexed as

AlgorithmsGenetic Association StudiesModels, GeneticComputer SimulationHumansLogistic ModelsNeoplasm, ResidualPrecursor Cell Lymphoblastic Leukemia-Lymphomagenetic association studymultiple thresholdsOrdered logistic modelrare variantsset-valued system identification

Identifiers

PMID25959545
PMCPMC4474746

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.